{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT05193877",
      "OrgStudyIdInfo": {
        "OrgStudyId": "Ibn-sina protocol"
      },
      "Organization": {
        "OrgFullName": "Global Stem Cell Center, Baghdad",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis: a Randomized Controlled Trial, Baghdad 2022",
      "OfficialTitle": "Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis: a Randomized Controlled Trial, Ibn-Sina Hospital, Baghdad 2022"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2022",
      "OverallStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "February 2022",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "November 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 24, 2021",
      "StudyFirstSubmitQCDate": "January 12, 2022",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 18, 2022",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "January 12, 2022",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 18, 2022",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor-Investigator",
        "ResponsiblePartyInvestigatorFullName": "zaid husein ali",
        "ResponsiblePartyInvestigatorTitle": "global stem cell group",
        "ResponsiblePartyInvestigatorAffiliation": "Global Stem Cell Center, Baghdad"
      },
      "LeadSponsor": {
        "LeadSponsorName": "zaid husein ali",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "We present a randomized controlled trial (RCT) to assess the efï¬cacy of autologous bone marrow aspirate concentrate BMAC of 1.8x 10 9 median cellular content in the treatment of early symptomatic knee OA. We use 2 injections 2 months apart (8).",
      "DetailedDescription": "To evaluate the efficacy of bone marrow aspirate concentrate (BMAC) therapy on pain, function and disease modification in knee osteoarthritis.\nTo determine the potential of BMAC therapy to achieve disease modification, as detected through radiological examination using magnetic resonance imaging (MRI) techniques.\nMethodology:\n\nA randomized controlled trial will be held in Ibn-Sina training hospital in Baghdad. All participants will complete written informed consent. The study will be a single centered trial.\n\nThe trial design will consist of 60 participant randomly and equally allocated to control and treatment group by simple random sampling. Participants will not be blinded to their treatment allocation. Control group will receive conventional treatment only. Intervention group will receive (2 injections) intra-articular injections of (4cc) per joint at (8 weeks' interval).\n\nIntervention:\n\n50 cc bone marrow aspirates concentrate after centrifugation with final volume up to 7 cc.\n\nAssess total nucleated count and viability. Bone marrow aspirate concentrate is chosen as a source of mesenchymal stem cells, because of safe and easy procedure.\n\nBone marrow aspiration is done under local or general anesthesia, depending on the individual case. Around 50 cc of bone marrow is aspirated from the posterior iliac crest after proper sterilization using bone marrow aspiration needle (size according to the patient) and collected in heparinized syringes. Mononuclear cells (MNCs) are obtained by centrifugation. The isolated MNCs are checked for viability manually and confirmed on automated cell count machine.\n\nThe separated MNCs is administered intra-articularly immediately after centrifugation.\n\nPlace:\n\nBone marrow aspiration and centrifugation procedure is done in clean area, in operation room HEPA filtered with all instruments included. Cell count viability and flow cytometry can be sent to nearby lab.CD markers (90, 44,29,105,34).\n\nInstruments:\n\nBone marrow aspiration kit, centrifuge, automated cell counter.\n\nSample size and sampling technique:\n\nThe conventional treatment is usually classic treatment .\n\nStatistical analysis:\n\nRaw data will be summarized, and presented in appropriate table. The statistical analysis will be carried out using SPSS (statistical package for social science) software version 25"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Treatment Complication"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignInterventionModelDescription": "double blind",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Single",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "60",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "treatment with autologous bone marrow aspirate concentrate",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "autologous bone marrow aspirate is taken under local anesthesia to be centrifuged and the concentrate given intra articularly in knee joint",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: autologous bone marrow aspirate concentrate by centrifugation"
              ]
            }
          },
          {
            "ArmGroupLabel": "control",
            "ArmGroupType": "Sham Comparator",
            "ArmGroupDescription": "control group given analgesics only",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: autologous bone marrow aspirate concentrate by centrifugation"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Procedure",
            "InterventionName": "autologous bone marrow aspirate concentrate by centrifugation",
            "InterventionDescription": "50 cc bone marrow aspirates concentrate after centrifugation with final volume up to 7 cc.\n\nAssess total nucleated count and viability. Bone marrow aspirate concentrate is chosen as a source of mesenchymal stem cells, because of safe and easy procedure.\n\nBone marrow aspiration is done under local or general anesthesia, depending on the individual case. Around 50 cc of bone marrow is aspirated from the posterior iliac crest after proper sterilization using bone marrow aspiration needle (size according to the patient) and collected in heparinized syringes. Mononuclear cells (MNCs) are obtained by centrifugation. The isolated MNCs are checked for viability manually and confirmed on automated cell count machine.\n\nThe separated MNCs is administered intra-articularly immediately after centrifugation.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "control",
                "treatment with autologous bone marrow aspirate concentrate"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "clinical",
            "PrimaryOutcomeDescription": "improvement in pain scale WOMAC",
            "PrimaryOutcomeTimeFrame": "6 months"
          },
          {
            "PrimaryOutcomeMeasure": "clinical",
            "PrimaryOutcomeDescription": "improvement in VAS scale",
            "PrimaryOutcomeTimeFrame": "6 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "radiological proof",
            "SecondaryOutcomeDescription": "MRI of the knee joint to monitor effect",
            "SecondaryOutcomeTimeFrame": "6 months-1 year"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nRadiological diagnosis of Osteoarthritis according to Kellgren and Lawrence Criteria stage II-III.\n\nRadiological grading of osteoarthritis of the knee determined by qualified radiologist using MOAKS scoring system.\nPrimary osteoarthritis not responsive to conventional treatment and physiotherapy.\nA minimum pain score of 5 on an 11-point numerical scale.\nAge >55 years\n\nExclusion Criteria:\n\nPregnancy and breast feeding.\nKnee symptom due to other condition like tumor or referred pain from lumbar spine.\nMRI confirmed displaced meniscal tear\nMRI confirmed Grade IV chondral loss.\nPrevious knee surgery within the last 12 months.\nPrevious intra-articular injectable therapies within the last 6 months\nHistory of severe systemic illness.\nActive neoplasm under treatment in the last 12 months- Health conditions including known allergy to local\nBleeding tendency.",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "All",
      "MinimumAge": "55 Years",
      "MaximumAge": "85 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "abdulmajeed hammadi, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+9647902268105",
            "CentralContactEMail": "majeed51578@yahoo.co.uk"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M3259",
            "InterventionBrowseLeafName": "Anesthetics",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3184",
            "InterventionBrowseLeafName": "Analgesics",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "CNSDep",
            "InterventionBrowseBranchName": "Central Nervous System Depressants"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          },
          {
            "InterventionBrowseBranchAbbrev": "Analg",
            "InterventionBrowseBranchName": "Analgesics"
          }
        ]
      }
    }
  }
}